As four not-for-profit health systems unveiled plans to create their own generic-drug company, experts say they'll face an uphill battle to make a significant dent in rising drug prices and shortages.
In a coordinated, bipartisan letter, the nation's governors made more than two dozen recommendations to President Donald Trump and Congress to bolster the fight against the opioid crisis.
HHS has launched a new a conscience and religious freedom division in its Office for Civil Rights. Agency officials said it was in response to increased complaints that providers' religious beliefs were not being respected in healthcare settings.
The interoperability rule would deal with some provisions of the 21st Century Cures Act, including health information networks' use of a framework for data transfer.
Pharmaceutical stocks dipped Thursday following the announcement that four large health systems will partner to create a not-for-profit generic drug company.
About 91% of the ACOs in non-risk bearing tracks in 2016 would have saved an additional $966 million overall if they were in a contract with downside risk, according to an Avalere Health analysis released Thursday.
In the face of a potential government shutdown, senators are clamoring for a few extra days to work out a spending deal. Hospitals hope this means another chance to pack Medicare extenders and DSH cut delays into the final bill.
Intermountain Healthcare, Ascension, SSM Health and Trinity Health have joined forces to create a generic-drug company to create cheaper and more available alternatives than they can now obtain on the market.
A new report from the Bipartisan Policy Center and the Center for Outcomes Research and Education finds that many stakeholders in seven rural states believe rural communities should transform their critical-access hospitals into hybrid clinics that provide primary care and emergency services.
CMS Administrator Seema Verma revealed the agency will convene a group to review the Stark law and how it's impeding providers' move to value-based care.
A new study found the CMS' Medicare Part D program could have saved $3.4 billion between 2012 and 2015 if the agency required generic substitutes for 62 brand-name drugs that weren't covered by the two largest pharmacy benefit managers.
The CMS will propose limiting Medicare enrollees' ability to go to multiple providers or pharmacies to obtain pain medication, a tool that the agency believes will be crucial in combating the ongoing opioid epidemic.